• 1. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 2. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 3. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 4. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 5. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583

Professional Introduction to 4-(5-Oxazolyl)benzylamine (CAS No: 672324-91-3)

4-(5-Oxazolyl)benzylamine, identified by its Chemical Abstracts Service (CAS) number 672324-91-3, is a significant compound in the field of pharmaceutical chemistry and bioorganic synthesis. This compound belongs to the class of oxazole derivatives, which have garnered considerable attention due to their diverse biological activities and potential applications in drug development. The structural motif of 4-(5-Oxazolyl)benzylamine combines the benzylamine moiety with an oxazole ring, creating a versatile scaffold that can be further modified for various pharmacological purposes.

The< strong>4-(5-Oxazolyl)benzylamine molecule exhibits unique chemical properties that make it valuable in synthetic chemistry. The presence of the oxazole ring imparts electron-deficient characteristics, while the benzylamine group contributes to basicity and nucleophilicity. These features are particularly useful in designing molecules that interact with biological targets such as enzymes and receptors. The compound's ability to participate in various chemical reactions, including nucleophilic substitutions and condensations, makes it a valuable intermediate in the synthesis of more complex pharmaceutical agents.

In recent years, there has been growing interest in oxazole derivatives due to their broad spectrum of biological activities. Studies have demonstrated that compounds containing the oxazole scaffold exhibit properties such as antimicrobial, anti-inflammatory, and anticancer effects. The< strong>4-(5-Oxazolyl)benzylamine derivative, in particular, has shown promise in preliminary investigations as a potential lead compound for further drug development. Its structural features allow for modifications that can enhance its binding affinity and selectivity towards specific biological targets.

One of the most compelling aspects of 4-(5-Oxazolyl)benzylamine is its potential application in the design of kinase inhibitors. Kinases are enzymes that play crucial roles in cell signaling pathways and are frequently implicated in various diseases, including cancer. By incorporating the oxazole ring into a benzylamine framework, researchers can create molecules that selectively inhibit specific kinases without affecting others. This specificity is essential for developing effective therapeutics with minimal side effects. Recent studies have highlighted the importance of oxazole derivatives in modulating kinase activity, making 4-(5-Oxazolyl)benzylamine a promising candidate for further exploration.

The synthesis of 4-(5-Oxazolyl)benzylamine involves multi-step organic transformations that require careful optimization to achieve high yields and purity. Common synthetic routes include the condensation of 2-amino-5-oxazolecarboxylic acid with benzaldehyde derivatives, followed by functional group modifications. Advances in synthetic methodologies have enabled more efficient and scalable production processes, which are crucial for industrial applications. The ability to produce< strong> 4-(5-Oxazolyl)benzylamine reliably and cost-effectively is essential for its integration into pharmaceutical pipelines.

In addition to its potential as a kinase inhibitor, 4-(5-Oxazolyl)benzylamine has shown promise in other therapeutic areas. For instance, its structural similarity to known antimicrobial agents suggests that it could be developed into novel antibiotics or antifungal drugs. The oxazole ring's ability to interact with bacterial enzymes has been exploited in several drug designs aimed at combating resistant strains of pathogens. Furthermore, the benzylamine group can be modified to enhance solubility and bioavailability, making< strong > 4-(5-Oxazolyl)benzylamine a versatile building block for various therapeutic applications.

The pharmacological evaluation of< strong > 4-(5-Oxazolyl)benzylamine has revealed several interesting properties. In vitro studies have demonstrated its ability to inhibit the growth of certain cancer cell lines by disrupting key signaling pathways. Additionally, it has shown activity against inflammatory cytokines, suggesting potential benefits in treating autoimmune diseases. These findings underscore the compound's broad therapeutic potential and justify further preclinical and clinical investigations.

The development of novel pharmaceuticals relies heavily on innovative synthetic strategies and interdisciplinary collaboration between chemists, biologists, and pharmacologists. The< strong > 4-(5-Oxazolyl)benzylamine derivative exemplifies how structurally diverse compounds can serve as valuable starting points for drug discovery efforts. By leveraging the unique properties of oxazole derivatives, researchers can design molecules with tailored biological activities that address unmet medical needs.

In conclusion, 4-(5-Oxazolyl)benzylamine (CAS No: 672324-91-3) is a multifaceted compound with significant potential in pharmaceutical research and development. Its structural features enable diverse modifications, making it a valuable intermediate for synthesizing biologically active molecules. Recent studies highlight its promise as a lead compound for kinase inhibitors and other therapeutic agents. As synthetic methodologies continue to evolve, the accessibility of< strong > 4-(5-Oxazolyl)benzylamine will facilitate further exploration of its pharmacological applications.

• 157837-31-5(3-(1,3-Oxazol-5-yl)aniline)
• 179057-31-9(4-(1,3-oxazol-5-yl)benzaldehyde)
• 143659-19-2(5-(4-Methylphenyl)-1,3-oxazole)
• 774238-36-7(2-(5-Oxazolyl)aniline)
• 1006-68-4(5-Phenyloxazole)
• 501944-63-4(5-(4-Ethynylphenyl)-1,3-oxazole)
• 1008-95-3(4-(1,3-Oxazol-5-yl)aniline)
• 87150-13-8(4-(5-Oxazolyl)benzonitrile)
• 143659-20-5(Oxazole,5-(2-naphthalenyl)-)
• 1128-71-8(4-(5-Oxazolyl)phenol)